Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C8H11N7S |
| Molecular Weight | 237.285 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
NC(=N)NN=C1C=CC(C=C1)=NNC(N)=S
InChI
InChIKey=MLMFUKWWZIZRHX-UWRPRBHNSA-N
InChI=1S/C8H11N7S/c9-7(10)14-12-5-1-3-6(4-2-5)13-15-8(11)16/h1-4H,(H4,9,10,14)(H3,11,15,16)/b12-5-,13-6+
| Molecular Formula | C8H11N7S |
| Molecular Weight | 237.285 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 1 |
| Optical Activity | NONE |
Ambazone (1,4-benzoquinone guanylhydrazone thiosemicarbazone) is an antibacterial agent.
It exerts antitumor activity both in vitro and in vivo.
Ambazone is indicated in the treatment of infections of the mouth and throat, including tonsillitis, gingivitis, stomatitis, as well as after tonsillectomy, after tooth extraction.
Originator
Approval Year
Sample Use Guides
Faringosept (ambazone 10 mg). 3-5 tablets daily for 3-4 days. The tablets should be sucked slowly. The tablets should not be swallowed but allowed to slowly dissolve in the mouth. Use 15-30 minutes after a meal; after using the preparation, do not eat or drink fluids for 2-3 hours.
Route of Administration:
Topical
| Substance Class |
Chemical
Created
by
admin
on
Edited
Wed Apr 02 09:29:40 GMT 2025
by
admin
on
Wed Apr 02 09:29:40 GMT 2025
|
| Record UNII |
BYK4592A3Q
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C28394
Created by
admin on Wed Apr 02 09:29:40 GMT 2025 , Edited by admin on Wed Apr 02 09:29:40 GMT 2025
|
||
|
NCI_THESAURUS |
C274
Created by
admin on Wed Apr 02 09:29:40 GMT 2025 , Edited by admin on Wed Apr 02 09:29:40 GMT 2025
|
||
|
WHO-VATC |
QR02AA01
Created by
admin on Wed Apr 02 09:29:40 GMT 2025 , Edited by admin on Wed Apr 02 09:29:40 GMT 2025
|
||
|
WHO-ATC |
R02AA01
Created by
admin on Wed Apr 02 09:29:40 GMT 2025 , Edited by admin on Wed Apr 02 09:29:40 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
BYK4592A3Q
Created by
admin on Wed Apr 02 09:29:40 GMT 2025 , Edited by admin on Wed Apr 02 09:29:40 GMT 2025
|
PRIMARY | |||
|
C72627
Created by
admin on Wed Apr 02 09:29:40 GMT 2025 , Edited by admin on Wed Apr 02 09:29:40 GMT 2025
|
PRIMARY | |||
|
m552
Created by
admin on Wed Apr 02 09:29:40 GMT 2025 , Edited by admin on Wed Apr 02 09:29:40 GMT 2025
|
PRIMARY | Merck Index | ||
|
SUB12841MIG
Created by
admin on Wed Apr 02 09:29:40 GMT 2025 , Edited by admin on Wed Apr 02 09:29:40 GMT 2025
|
PRIMARY | |||
|
C037931
Created by
admin on Wed Apr 02 09:29:40 GMT 2025 , Edited by admin on Wed Apr 02 09:29:40 GMT 2025
|
PRIMARY | |||
|
AMBAZONE
Created by
admin on Wed Apr 02 09:29:40 GMT 2025 , Edited by admin on Wed Apr 02 09:29:40 GMT 2025
|
PRIMARY | |||
|
DB13697
Created by
admin on Wed Apr 02 09:29:40 GMT 2025 , Edited by admin on Wed Apr 02 09:29:40 GMT 2025
|
PRIMARY | |||
|
539-21-9
Created by
admin on Wed Apr 02 09:29:40 GMT 2025 , Edited by admin on Wed Apr 02 09:29:40 GMT 2025
|
PRIMARY | |||
|
100000077683
Created by
admin on Wed Apr 02 09:29:40 GMT 2025 , Edited by admin on Wed Apr 02 09:29:40 GMT 2025
|
PRIMARY | |||
|
DTXSID3046407
Created by
admin on Wed Apr 02 09:29:40 GMT 2025 , Edited by admin on Wed Apr 02 09:29:40 GMT 2025
|
PRIMARY | |||
|
145
Created by
admin on Wed Apr 02 09:29:40 GMT 2025 , Edited by admin on Wed Apr 02 09:29:40 GMT 2025
|
PRIMARY | |||
|
208-713-0
Created by
admin on Wed Apr 02 09:29:40 GMT 2025 , Edited by admin on Wed Apr 02 09:29:40 GMT 2025
|
PRIMARY | |||
|
822
Created by
admin on Wed Apr 02 09:29:40 GMT 2025 , Edited by admin on Wed Apr 02 09:29:40 GMT 2025
|
PRIMARY | |||
|
1549158
Created by
admin on Wed Apr 02 09:29:40 GMT 2025 , Edited by admin on Wed Apr 02 09:29:40 GMT 2025
|
PRIMARY | |||
|
CHEMBL2103762
Created by
admin on Wed Apr 02 09:29:40 GMT 2025 , Edited by admin on Wed Apr 02 09:29:40 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
SALT/SOLVATE -> PARENT | |||
|
SOLVATE->ANHYDROUS |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |